Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 339

1.

Evidence of CD40L/CD40 pathway involvement in experimental transfusion-related acute lung injury.

Tariket S, Hamzeh-Cognasse H, Laradi S, Arthaud CA, Eyraud MA, Bourlet T, Berthelot P, Garraud O, Cognasse F.

Sci Rep. 2019 Aug 29;9(1):12536. doi: 10.1038/s41598-019-49040-0.

2.

Platelet Inflammatory Response to Stress.

Cognasse F, Laradi S, Berthelot P, Bourlet T, Marotte H, Mismetti P, Garraud O, Hamzeh-Cognasse H.

Front Immunol. 2019 Jun 28;10:1478. doi: 10.3389/fimmu.2019.01478. eCollection 2019. Review.

3.

Interplay of nasal and rectal carriage of Staphylococcus aureus in intensive care unit patients.

Gagnaire J, Botelho-Nevers E, Martin-Simoes P, Morel J, Zéni F, Maillard N, Mariat C, Haddar CH, Carricajo A, Fonsale N, Grattard F, Pozzetto B, Laurent F, Berthelot P, Verhoeven PO.

Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1811-1819. doi: 10.1007/s10096-019-03613-z. Epub 2019 Jul 4.

PMID:
31273646
4.

Acute kidney injury in infective endocarditis: A retrospective analysis.

Gagneux-Brunon A, Pouvaret A, Maillard N, Berthelot P, Lutz MF, Cazorla C, Tulane C, Fuzellier JF, Verhoeven PO, Frésard A, Duval X, Lucht F, Botelho-Nevers E.

Med Mal Infect. 2019 Oct;49(7):527-533. doi: 10.1016/j.medmal.2019.03.015. Epub 2019 Apr 4.

PMID:
30955847
5.

Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.

Slekovec C, Robert J, van der Mee-Marquet N, Berthelot P, Rogues AM, Derouin V, Cholley P, Thouverez M, Hocquet D, Bertrand X.

Eur J Clin Microbiol Infect Dis. 2019 May;38(5):921-926. doi: 10.1007/s10096-019-03519-w. Epub 2019 Mar 2.

PMID:
30826996
6.

Inhibition of the CD40/CD40L complex protects mice against ALI-induced pancreas degradation.

Tariket S, Hamzeh-Cognasse H, Arthaud CA, Laradi S, Bourlet T, Berthelot P, Garraud O, Cognasse F.

Transfusion. 2019 Mar;59(3):1090-1101. doi: 10.1111/trf.15206. Epub 2019 Feb 19.

PMID:
30784079
7.

Impact of amoxicillin and oral amoxicillin-clavulanic acid defined daily doses on consumption indicators.

Charra F, Berthelot P, Bergheau F.

Med Mal Infect. 2019 May;49(3):208-213. doi: 10.1016/j.medmal.2018.10.009. Epub 2018 Nov 20.

PMID:
30470484
8.

Penicillins' defined daily doses must be changed.

Charra F, Berthelot P, Bergheau F.

Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):E11432. doi: 10.1073/pnas.1816558115. Epub 2018 Nov 13. No abstract available.

9.

Intracellular activity of antimicrobial compounds used for Staphylococcus aureus nasal decolonization.

Rigaill J, Morgene MF, Gavid M, Lelonge Y, He Z, Carricajo A, Grattard F, Pozzetto B, Berthelot P, Botelho-Nevers E, Verhoeven PO.

J Antimicrob Chemother. 2018 Nov 1;73(11):3044-3048. doi: 10.1093/jac/dky318.

PMID:
30124897
10.

HaCaT epithelial cells as an innovative novel model of rhinovirus infection and impact of clarithromycin treatment on infection kinetics.

Morgene MF, Maurin C, Pillet S, Berthelot P, Morfin F, Pozzetto B, Botelho-Nevers E, Verhoeven PO.

Virology. 2018 Oct;523:27-34. doi: 10.1016/j.virol.2018.07.025. Epub 2018 Aug 1.

PMID:
30077071
11.

Staphylococcus aureus colonization and non-influenza respiratory viruses: Interactions and synergism mechanisms.

Morgene MF, Botelho-Nevers E, Grattard F, Pillet S, Berthelot P, Pozzetto B, Verhoeven PO.

Virulence. 2018;9(1):1354-1363. doi: 10.1080/21505594.2018.1504561. Review.

12.

Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors.

Oyallon B, Brachet-Botineau M, Logé C, Bonnet P, Souab M, Robert T, Ruchaud S, Bach S, Berthelot P, Gouilleux F, Viaud-Massuard MC, Denevault-Sabourin C.

Eur J Med Chem. 2018 Jun 25;154:101-109. doi: 10.1016/j.ejmech.2018.04.056. Epub 2018 May 11.

PMID:
29778892
13.

Vaccines for healthcare-associated infections: present, future, and expectations.

Gagneux-Brunon A, Lucht F, Launay O, Berthelot P, Botelho-Nevers E.

Expert Rev Vaccines. 2018 May;17(5):421-433. doi: 10.1080/14760584.2018.1470507. Epub 2018 May 7. Review.

PMID:
29697286
14.

The Non-Hemostatic Aspects of Transfused Platelets.

Sut C, Tariket S, Aubron C, Aloui C, Hamzeh-Cognasse H, Berthelot P, Laradi S, Greinacher A, Garraud O, Cognasse F.

Front Med (Lausanne). 2018 Feb 27;5:42. doi: 10.3389/fmed.2018.00042. eCollection 2018. Review.

15.

Platelet toll-like receptors are crucial sensors of infectious danger moieties.

Hamzeh-Cognasse H, Berthelot P, Tardy B, Pozzetto B, Bourlet T, Laradi S, Garraud O, Cognasse F.

Platelets. 2018 Sep;29(6):533-540. doi: 10.1080/09537104.2018.1445842. Epub 2018 Mar 13. Review.

PMID:
29533683
16.

Hospital-acquired infections documented by repeated annual prevalence surveys over 15 years.

Spiga R, Subtil F, Grattard F, Fascia P, Mariat C, Auboyer C, Lucht F, Pozzetto B, Berthelot P.

Med Mal Infect. 2018 Mar;48(2):136-140. doi: 10.1016/j.medmal.2017.11.008. Epub 2017 Dec 21.

PMID:
29276158
17.

The French Infectious Diseases Society's readiness and response to epidemic or biological risk-the current situation following the Middle East respiratory syndrome coronavirus and Ebola virus disease alerts.

Coignard-Biehler H, Rapp C, Chapplain JM, Hoen B, Che D, Berthelot P, Cazenave-Roblot F, Rabaud C, Brouqui P, Leport C; SPILF-COREB Emergences group.

Med Mal Infect. 2018 Mar;48(2):95-102. doi: 10.1016/j.medmal.2017.10.002. Epub 2017 Nov 21.

PMID:
29169817
18.

Epidemiology and clinical relevance of Staphylococcus aureus intestinal carriage: a systematic review and meta-analysis.

Gagnaire J, Verhoeven PO, Grattard F, Rigaill J, Lucht F, Pozzetto B, Berthelot P, Botelho-Nevers E.

Expert Rev Anti Infect Ther. 2017 Aug;15(8):767-785. doi: 10.1080/14787210.2017.1358611. Epub 2017 Jul 27. Review.

PMID:
28726558
19.

Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains.

Chabert A, Damien P, Verhoeven PO, Grattard F, Berthelot P, Zeni F, Panicot-Dubois L, Robert S, Dignat-George F, Eyraud MA, Pozzetto B, Payrastre B, Cognasse F, Garraud O, Hamzeh-Cognasse H.

Sci Rep. 2017 Jul 17;7(1):5610. doi: 10.1038/s41598-017-06024-2.

20.

Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression.

Pirat C, Dacquet C, Leclerc V, Hennuyer N, Beucher-Gaudin M, Zanirato G, Géant A, Staels B, Ktorza A, Farce A, Caignard DH, Berthelot P, Lebegue N.

Eur J Med Chem. 2017 Sep 8;137:310-326. doi: 10.1016/j.ejmech.2017.06.006. Epub 2017 Jun 12.

PMID:
28609708
21.

Extensively drug-resistant bacteria: Which ethical issues?

Vassal P, Berthelot P, Chaussinand JP, Jay S, de Filippis JP, Auboyer C, Renoux F, Bedoin D.

Med Mal Infect. 2017 Sep;47(5):319-323. doi: 10.1016/j.medmal.2016.08.002. Epub 2017 May 16.

PMID:
28526428
22.

Carbapenemase-producing Acinetobacter baumannii: An outbreak report with special highlights on economic burden.

Gagnaire J, Gagneux-Brunon A, Pouvaret A, Grattard F, Carricajo A, Favier H, Mattei A, Pozzetto B, Nuti C, Lucht F, Berthelot P, Botelho-Nevers E.

Med Mal Infect. 2017 Jun;47(4):279-285. doi: 10.1016/j.medmal.2017.02.006. Epub 2017 Mar 23.

PMID:
28343727
23.

New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation.

Landagaray E, Ettaoussi M, Rami M, Boutin JA, Caignard DH, Delagrange P, Melnyk P, Berthelot P, Yous S.

Eur J Med Chem. 2017 Feb 15;127:621-631. doi: 10.1016/j.ejmech.2016.12.013. Epub 2017 Jan 3.

PMID:
28131094
24.

Decolonization of Staphylococcus aureus carriage.

Botelho-Nevers E, Gagnaire J, Verhoeven PO, Cazorla C, Grattard F, Pozzetto B, Berthelot P, Lucht F.

Med Mal Infect. 2017 Sep;47(5):305-310. doi: 10.1016/j.medmal.2016.10.005. Epub 2016 Nov 14. Review.

PMID:
27856080
25.

Synthesis and Biological Evaluation of N-[2-(4-Hydroxyphenylamino)-pyridin-3-yl]-4-methoxy-benzenesulfonamide (ABT-751) Tricyclic Analogues as Antimitotic and Antivascular Agents with Potent in Vivo Antitumor Activity.

Segaoula Z, Leclercq J, Verones V, Flouquet N, Lecoeur M, Ach L, Renault N, Barczyk A, Melnyk P, Berthelot P, Thuru X, Lebegue N.

J Med Chem. 2016 Sep 22;59(18):8422-40. doi: 10.1021/acs.jmedchem.6b00847. Epub 2016 Aug 30.

26.

Vaccine hesitancy among general practitioners: evaluation and comparison of their immunisation practice for themselves, their patients and their children.

Killian M, Detoc M, Berthelot P, Charles R, Gagneux-Brunon A, Lucht F, Pulcini C, Barbois S, Botelho-Nevers E.

Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1837-1843. Epub 2016 Aug 3.

PMID:
27488435
27.

Corrigendum to "Contamination of healthcare workers' mobile phones by epidemic viruses" [Clin Microbiol Infect (2016) 456.e1-456.e6].

Pillet S, Berthelot P, Gagneux-Brunon A, Mory O, Gay C, Viallon A, Lucht F, Pozzetto B, Botelho-Nevers E.

Clin Microbiol Infect. 2016 Sep;22(9):e21. doi: 10.1016/j.cmi.2016.07.024. Epub 2016 Jul 25. No abstract available.

28.

Prospective evaluation of RT-PCR on sputum versus culture, urinary antigens and serology for Legionnaire's disease diagnosis.

Botelho-Nevers E, Grattard F, Viallon A, Allegra S, Jarraud S, Verhoeven P, Marcuccilli A, Lucht F, Pozzetto B, Berthelot P.

J Infect. 2016 Aug;73(2):123-8. doi: 10.1016/j.jinf.2016.04.039. Epub 2016 Jun 13.

PMID:
27306488
29.

Identifying Hemodialysis Patients With the Highest Risk of Staphylococcus aureus Endogenous Infection Through a Simple Nasal Sampling Algorithm.

Verhoeven PO, Gagnaire J, Haddar CH, Grattard F, Thibaudin D, Afiani A, Cazorla C, Carricajo A, Mariat C, Alamartine E, Lucht F, Garraud O, Pozzetto B, Botelho-Nevers E, Berthelot P.

Medicine (Baltimore). 2016 Apr;95(14):e3231. doi: 10.1097/MD.0000000000003231.

30.

Synthesis of triazoloquinazolinone based compounds as tubulin polymerization inhibitors and vascular disrupting agents.

Driowya M, Leclercq J, Verones V, Barczyk A, Lecoeur M, Renault N, Flouquet N, Ghinet A, Berthelot P, Lebegue N.

Eur J Med Chem. 2016 Jun 10;115:393-405. doi: 10.1016/j.ejmech.2016.03.056. Epub 2016 Mar 22.

PMID:
27031215
31.

Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.

Landagaray E, Ettaoussi M, Duroux R, Boutin JA, Caignard DH, Delagrange P, Melnyk P, Berthelot P, Yous S.

Eur J Med Chem. 2016 Feb 15;109:360-70. doi: 10.1016/j.ejmech.2015.12.047. Epub 2015 Dec 29.

PMID:
26820449
32.

[Survey among French dialysis practitioners about the screening and decolonization of nasal Staphylococcus aureus carriage in dialysis patients].

Botelho-Nevers É, Verhoeven PO, Thibaudin D, Gagnaire J, Gagneux-Brunon A, Lucht F, Berthelot P, Mariat C.

Nephrol Ther. 2016 Jul;12(4):206-9. doi: 10.1016/j.nephro.2015.11.002. Epub 2015 Dec 24. French.

PMID:
26725174
33.

Contamination of healthcare workers' mobile phones by epidemic viruses.

Pillet S, Berthelot P, Gagneux-Brunon A, Mory O, Gay C, Viallon A, Lucht F, Pozzetto B, Botelho-Nevers E.

Clin Microbiol Infect. 2016 May;22(5):456.e1-6. doi: 10.1016/j.cmi.2015.12.008. Epub 2015 Dec 20. Erratum in: Clin Microbiol Infect. 2016 Sep;22(9):e21.

34.

Preventing healthcare-associated infections: Residents and attending physicians need better training in advanced isolation precautions.

Moriceau G, Gagneux-Brunon A, Gagnaire J, Mariat C, Lucht F, Berthelot P, Botelho-Nevers E.

Med Mal Infect. 2016 Feb;46(1):14-9. doi: 10.1016/j.medmal.2015.11.001. Epub 2015 Dec 2.

PMID:
26654322
35.

Putting On and Removing Personal Protective Equipment.

Grandbastien B, Parneix P, Berthelot P; French High Council for Public Health; French Society for Hospital Hygiene.

N Engl J Med. 2015 Jun 18;372(25):2464. doi: 10.1056/NEJMc1504851. No abstract available.

PMID:
26083220
36.

French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission.

Lepelletier D, Berthelot P, Lucet JC, Fournier S, Jarlier V, Grandbastien B; National Working Group.

J Hosp Infect. 2015 Jul;90(3):186-95. doi: 10.1016/j.jhin.2015.04.002. Epub 2015 Apr 24. Review.

PMID:
25986165
37.

Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.

Lepelletier D, Lucet JC, Astagneau P, Coignard B, Vaux S, Rabaud C, Grandbastien B, Berthelot P.

Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1615-20. doi: 10.1007/s10096-015-2396-8. Epub 2015 May 10.

PMID:
25957988
38.

Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.

Pillet S, Jarlot C, Courault M, Del Tedesco E, Chardon R, Saint-Sardos P, Presles E, Phelip JM, Berthelot P, Pozzetto B, Roblin X.

Inflamm Bowel Dis. 2015 Jul;21(7):1580-6. doi: 10.1097/MIB.0000000000000412.

PMID:
25933392
39.

Molecular dynamics of Staphylococcus aureus nasal carriage in Hajj pilgrims.

Verhoeven PO, Gautret P, Haddar CH, Benkouiten S, Gagnaire J, Belhouchat K, Grattard F, Charrel R, Pozzetto B, Drali T, Lucht F, Brouqui P, Memish ZA, Berthelot P, Botelho-Nevers E.

Clin Microbiol Infect. 2015 Jul;21(7):650.e5-8. doi: 10.1016/j.cmi.2015.03.020. Epub 2015 Apr 13.

40.

[Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues].

Lepelletier D, Batard E, Berthelot P, Zahar JR, Lucet JC, Fournier S, Jarlier V, Grandbastien B.

Rev Med Interne. 2015 Jul;36(7):474-9. doi: 10.1016/j.revmed.2014.12.006. Epub 2015 Jan 15. Review. French.

PMID:
25600328
41.

Does pharyngeal sampling improve the detection of nasopharyngeal persistent carriers of Staphylococcus aureus?

Verhoeven PO, Haddar CH, Grattard F, Carricajo A, Botelho-Nevers E, Pozzetto B, Berthelot P.

J Infect. 2015 May;70(5):549-52. doi: 10.1016/j.jinf.2015.01.003. Epub 2015 Jan 9. No abstract available.

PMID:
25583209
42.

Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II).

Ettaoussi M, Pérès B, Errazani A, Boutin JA, Caignard DH, Delagrange P, Melnyk P, Berthelot P, Yous S.

Eur J Med Chem. 2015 Jan 27;90:822-33. doi: 10.1016/j.ejmech.2014.12.021. Epub 2014 Dec 13.

PMID:
25528336
43.

Health care-associated hepatitis C virus infection.

Pozzetto B, Memmi M, Garraud O, Roblin X, Berthelot P.

World J Gastroenterol. 2014 Dec 14;20(46):17265-78. doi: 10.3748/wjg.v20.i46.17265. Review.

44.

Are the risk factors associated with Staphylococcus aureus nasal carriage in patients the same than in healthy volunteers? Data from a cohort of patients scheduled for orthopedic material implantation.

Botelho-Nevers E, Berthelot P, Verhoeven PO, Grattard F, Cazorla C, Farizon F, Pozzetto B, Lucht F.

Am J Infect Control. 2014 Oct;42(10):1121-3. doi: 10.1016/j.ajic.2014.06.026.

PMID:
25278408
45.

Vascular catheter-related infection claims to health insurance company: often preventable.

Gagneux-Brunon A, Timsit JF, Lepape A, Berthelot P.

Clin Microbiol Infect. 2014 Dec;20(12):O1084-7. doi: 10.1111/1469-0691.12684. Epub 2014 Jun 14.

46.

Evaluating the impact of pluridisciplinary training on proper glove use in hospital.

Turco M, Chalaye C, Poulard E, Gocko C, Neyron C, Courbon G, Berthelot P.

Med Mal Infect. 2014 Jun;44(6):268-74. doi: 10.1016/j.medmal.2014.04.001. Epub 2014 May 16.

PMID:
24838085
47.

"Preoperative risk management: strategy for Staphylococcus aureus preoperative decolonization" (2013 update). French society of Hospital Hygiene.

Lepelletier D, Saliou P, Lefebvre A, Lucet JC, Grandbastien B, Bruyère F, Stahl JP, Keita-Perse O, Berthelot P, Aho S; workgroup SF2H.

Med Mal Infect. 2014 Jun;44(6):261-7. doi: 10.1016/j.medmal.2014.04.003. Epub 2014 May 14. No abstract available.

PMID:
24835378
48.

Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.

Bedoin M, Cazorla C, Lucht F, Berthelot P, Boyer M, Carricajo A, Guérin T, Viallon A.

Med Mal Infect. 2014 May;44(5):206-16. doi: 10.1016/j.medmal.2014.02.003. Epub 2014 Apr 30.

PMID:
24794820
49.

Comparative evaluation of alcoholic handrub: science or marketing?

Berthelot P, Exner M.

Antimicrob Resist Infect Control. 2014 Apr 14;3:11. doi: 10.1186/2047-2994-3-11. eCollection 2014. No abstract available.

50.

New melatonin (MT1/MT2) ligands: design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives.

Landagaray E, Ettaoussi M, Leclerc V, Traoré B, Perez V, Nosjean O, Boutin JA, Caignard DH, Delagrange P, Berthelot P, Yous S.

Bioorg Med Chem. 2014 Feb 1;22(3):986-96. doi: 10.1016/j.bmc.2013.12.054. Epub 2014 Jan 3.

PMID:
24417958

Supplemental Content

Loading ...
Support Center